GALLBLADDER CARCINOMA

Clinical trials for GALLBLADDER CARCINOMA explained in plain language.

Never miss a new study

Get alerted when new GALLBLADDER CARCINOMA trials appear

Sign up with your email to follow new studies for GALLBLADDER CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 3 Not yet recruiting 1 Not yet finished but already full! 3 Completed 1 Terminated 1

Experimental cancer drug trial halted early

Disease control Terminated

This study tested a new drug called felmetatug vedotin, alone or with pembrolizumab, in people with advanced solid tumors (like ovarian, breast, lung, and others). The goal was to check safety and find the right dose. The trial was terminated early, so results are limited.

Matched conditions: GALLBLADDER CARCINOMA

Phase: PHASE1 • Sponsor: Seagen, a wholly owned subsidiary of Pfizer • Aim: Disease control

Last updated May 17, 2026 05:35 UTC

GALLBLADDER CARCINOMA

Get alerted when new GALLBLADDER CARCINOMA trials appear

Experimental cancer drug trial halted early